ENTITY

Altimmune (ALT US)

2
Analysis
Health CareUnited States
Altimmune, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of novel peptide-based therapeutics for the treatment of obesity, NASH, chronic hepatitis B, and liver diseases. Altimmune serves patients and healthcare professionals worldwide.
more
Company Event26 Feb 2026 21:30 • Upcoming
Add To Calendar
Company Event04 Dec 2025 03:30 • Latest
Company Event20 Nov 2025 16:00
Company Event12 Nov 2025 23:00
Company Event07 Nov 2025 05:00 • Upcoming
Add To Calendar
x